2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Lymphocyte-Rich Classical Hodgkin Lymphoma: new trials by email Literature Review of Lymphocyte-Rich Classical Hodgkin Lymphoma trials Research Report on Lymphocyte-Rich Classical Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma Computed Tomography, Dacarbazine, Doxorubicin Hydrochloride - Classical Hodgkin Lymphoma, Lymphocyte-Depleted Classical Hodgkin Lymphoma | Phase 2 | Unknown | Northwestern University | 30 | 2017-11-09 | 2023-06-02 |
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma Carboplatin, Etoposide, Ifosfamide - Lymphocyte-Rich Classical Hodgkin Lymphoma, Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma | Phase 2 | Unknown | Northwestern University | 43 | 2017-04-21 | 2023-06-02 |
Hodgkin Disease (2)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2)
pembrolizumab (2) · Carboplatin (1) · Dacarbazine (1) · Doxorubicin (1) · Etoposide (1) · Fluorodeoxyglucose F18 (1) · Ifosfamide (1) · Magnetic Resonance Spectroscopy (1) · Vinblastine (1)
United States (2)
Jane N. Winter, M.D. (1) · Jane Winter, M.D. (1)
PMID 32992341, PMID 36083129, PMID 36928527, PMID 40135712
P30CA060553 (2)